Fundraising

The firm has received backing from 15 institutions at the final close of its oil & gas focused fund, including a E25m commitment from Société Générale Asset Management.

Sovereign backs funeral buyout; Scottish Equity Partners leads BioVex round; Accent takes Cefar stake; Atlas leads Arrow Therapeutics financing; ING, Capricorn back TiGenix; Matrix leads Recite investment; Benchmark Capital funds Yoox; Apax backs $11m Iris round;

Terms in the partnership agreement governing Permira’s E5.1bn Europe III fund reflect private equity investors’ requirements to publicly disclose details of their participation in the asset class.

The Israeli venture capital firm has secured commitments from HarbourVest Partners and the Illinois Teachers Retirement System for its fourth fund.

The Irish bank has held a final close of its third collateralised debt obligation fund on E407m, increasing the total third party capital to invest in leveraged loans to E1.2bn.

The US investment bank has closed its GS Mezzanine Partners III fund on $2.7bn, making it the largest mezzanine fund ever raised.

Slovenia-based broker Poteza is hoping to raise E75m to invest in the South East European states of Slovenia, Croatia, Serbia & Montenegro and Bosnia & Herzegovina.

Englefield Capital has backed management at the UK-based underwriting business in a £30m buyout from US insurer Trenwick Group.

The Anglo-American life sciences VC firm has exceeded the original $275m target for their Abingworth Bioventures IV fund (ABV IV), which was more than two times over-susbscribed.

The European Bank for Reconstruction and Development has made a E15m commitment to Euroventures Hungary III, the latest fund to target one of the EU accession states.